Therapeutic scope of beta-adrenergic blocking agents
Canale, J.M.; Horwitz, S.
Archivos de Investigacion Medica 10(4): 261-277
1979
ISSN/ISBN: 0066-6769 PMID: 44180 Document Number: 154004
Document emailed within 1 workday
Related Documents
Tafreshi, M.J.; Weinacker, A.B. 1999: Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma PharmacoTherapy 19(8): 974-978Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Apponi-Battini, G.; Barra, A.; De Simone, C.; Rossi, F.; Berrino, L.; Cazzola, M.; Marmo, E. 1984: Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents Journal of Medicine 15(2): 126-134
Klevans, L.R.; Kovacs, J.L.; Kelly, R. 1976: Central effect of beta adrenergic blocking agents on arterial blood pressure Journal of Pharmacology and Experimental Therapeutics 196(2): 389-395
Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239
Ban, T. 1974: A quantitative study of the effects of isoproterenol and beta-adrenergic blocking agents in the rat uterus in situ Arzneimittel-Forschung 24(2): 179-181
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Singh, K.P. 1979: Modification of hexobarbitone sodium-induced hynosis in mice by beta adrenergic receptor blocking agents Indian Journal of Physiology and Pharmacology 23(1): 52-54
Tampier, L.; Alpers, H.S.; Davis, V.E. 1977: Influence of catecholamine-derived alkaloids and beta-adrenergic blocking agents on stereospecific binding of 3H-naloxone Research Communications in Chemical Pathology and Pharmacology 17(4): 731-734
Ongini, E.; Milani, S.; Marzanatti, M.; Trampus, M.; Monopoli, A. 1991: Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 257(1): 114-119
Merin, R.G. 1972: Anesthetic management problems posed by therapeutic advances: 3. Beta-adrenergic blocking drugs Anesthesia and Analgesia 51(4): 617-624
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Fernández, B.; Kaumann, A.J. 1975: Structure-basicity and structure-affinity relationships of beta-adrenergic blocking agents Acta Physiologica Latino Americana 25(1): 45-51